Register for Safety of Stem-Cell Derived Therapies: Trends and Future Technologies 7/8 October 2019

By | Acellular / smart materials – 3D architecture, Engineered cell environment, Event, Pluripotent stem cells and engineered cells, workshop

This important meeting, held at the John McIntyre Centre in Edinburgh on 7/8 October 2019, is brought to you by the UK Regenerative Medicine Platform (UKRMP) and the British Pharmacological Society.

Stem cell-derived therapies are complex and diverse, so it is critical that we understand the challenges faced in getting clinical trials for these therapies approved.

Across two days, we will discuss how some therapies have made progress towards clinical trials, particularly in relation to assessing safety. We will also look at areas where new technologies can fill vital gaps, such as in combination therapies with smart materials.

This meeting will be of particular interest to pharmacologists, those working in toxicology, clinicians, academics and industry. Regulators, including MHRA and FDA, will also be joining our panel discussions.

Hear from leaders in the field including Pete Coffey, Agnete Kirkeby, Martin Pera, Kevin Eggan and our key note speaker, Jane Lebkowski.

Find out more and register

This meeting will feature both oral communication and poster presentations. Please submit an abstract for the meeting before the deadline, 19 July 2019.

If you have any questions about the abstract submission process, please email

UKRMP-funded Virtual Tour opens its doors.

By | Engineered cell environment, Latest, Successes

Users are able to tour around the MRC Centre for Regenerative Medicine at the University of Edinburgh. Your guide is Sophie Quick, who is a PhD student at the Centre.

Use the following link to access the tour: 

The tour is a great tool for public engagement and outreach activities. Users can travel throughout the MRC CRM building and find out what it is like to be a researcher within this research centre. A great tool for all members of the UKRMP network.